Acadia Pharmaceuticals Stock Annual Yield

ACAD Stock  USD 17.17  0.30  1.78%   
ACADIA Pharmaceuticals fundamentals help investors to digest information that contributes to ACADIA Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of ACADIA Stock. The fundamental analysis module provides a way to measure ACADIA Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ACADIA Pharmaceuticals stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

ACADIA Pharmaceuticals Company Annual Yield Analysis

ACADIA Pharmaceuticals' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

 = 

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

ACADIA Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for ACADIA Pharmaceuticals is extremely important. It helps to project a fair market value of ACADIA Stock properly, considering its historical fundamentals such as Annual Yield. Since ACADIA Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ACADIA Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ACADIA Pharmaceuticals' interrelated accounts and indicators.
0.86-0.770.730.39-0.910.750.80.990.690.930.610.940.90.810.720.670.80.73
0.86-0.810.30.51-0.680.360.960.910.330.740.220.980.830.420.790.770.610.37
-0.77-0.81-0.36-0.470.57-0.37-0.64-0.81-0.24-0.65-0.09-0.83-0.63-0.41-0.72-0.7-0.5-0.39
0.730.3-0.360.02-0.850.940.220.630.90.750.90.450.690.980.320.240.80.96
0.390.51-0.470.02-0.240.110.510.440.110.40.030.490.310.050.10.10.070.02
-0.91-0.680.57-0.85-0.24-0.87-0.62-0.87-0.84-0.93-0.81-0.77-0.93-0.92-0.6-0.53-0.87-0.85
0.750.36-0.370.940.11-0.870.320.670.850.80.840.50.710.940.290.210.760.9
0.80.96-0.640.220.51-0.620.320.860.30.70.20.940.750.360.70.690.510.26
0.990.91-0.810.630.44-0.870.670.860.60.910.510.970.880.720.750.710.750.64
0.690.33-0.240.90.11-0.840.850.30.60.760.950.450.70.90.240.160.760.87
0.930.74-0.650.750.4-0.930.80.70.910.760.690.820.850.840.540.490.740.75
0.610.22-0.090.90.03-0.810.840.20.510.950.690.340.640.910.180.10.740.88
0.940.98-0.830.450.49-0.770.50.940.970.450.820.340.850.560.80.770.670.48
0.90.83-0.630.690.31-0.930.710.750.880.70.850.640.850.770.70.630.880.75
0.810.42-0.410.980.05-0.920.940.360.720.90.840.910.560.770.430.350.840.95
0.720.79-0.720.320.1-0.60.290.70.750.240.540.180.80.70.430.990.70.4
0.670.77-0.70.240.1-0.530.210.690.710.160.490.10.770.630.350.990.620.3
0.80.61-0.50.80.07-0.870.760.510.750.760.740.740.670.880.840.70.620.89
0.730.37-0.390.960.02-0.850.90.260.640.870.750.880.480.750.950.40.30.89
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition

In accordance with the recently published financial statements, ACADIA Pharmaceuticals has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

ACADIA Pharmaceuticals ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ACADIA Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ACADIA Pharmaceuticals' managers, analysts, and investors.
Environmental
Governance
Social

ACADIA Fundamentals

About ACADIA Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ACADIA Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACADIA Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACADIA Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ACADIA Pharmaceuticals is a strong investment it is important to analyze ACADIA Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ACADIA Pharmaceuticals' future performance. For an informed investment choice regarding ACADIA Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
28.347
Earnings Share
0.78
Revenue Per Share
5.622
Quarterly Revenue Growth
0.183
Return On Assets
0.0872
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.